Anne Knisely

6PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 01, 2025
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities.

Anne Knisely, Yibo Dai, Graham L Barlow

|Jul 31, 2024
Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare.

Anne Knisely, Chi-Fang Wu, Alexa Kanbergs

|Feb 03, 2024
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.

Rodabe Amaria, Anne Knisely, David Vining

|Nov 27, 2023
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.

Emily M Hinchcliff, Anne Knisely, Naomi Adjei

|Oct 21, 2023
Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.

Anne Knisely, Jibran Ahmed, Bettzy Stephen

|Feb 11, 2023
Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment.

Anne Knisely, Yongwoo David Seo, Jennifer A Wargo

Pageof 1

Frequent Collaborators

2 joint publications

Manoj Chelvanambi

2 joint publications

Anil K Sood

2 joint publications

Pamela T Soliman

2 joint publications

Roni Nitecki Wilke